AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21183857
Drug: Intravenous mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mannitol
Trial: 1757907
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium taurocholate
Trial: 6139318
Drug: Pindolol, 5
RxNorm normalized name: Pindolol, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol, 5 mg the evening before and on the morning, an hour prior to surgery
Trial: 29645086
Drug: Erlotinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib plus placebo (erlotinib 150 mg daily)
Trial: 12401597
Drug: 0.8 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mL/kg of 0.25% bupivacaine
Trial: 12401597
Drug: 1.0 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mL/kg of 0.2% bupivacaine
Trial: 2284217
Drug: Lornoxicam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam (4 mg dose, administered as an aqueous solution, orally and intravenously)
Trial: 26215551
Drug: Corticosteroid Injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid Injection (CSI)
Trial: 20463410
Drug: saxagliptin (2.5‐100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin (2.5‐100 mg/d)
Trial: 20463410
Drug: comparator (placebo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: comparator (placebo, metformin, uptitrated glyburide)
Trial: 16143229
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR 37.5 mg/day
Trial: 10199763
Drug: GnRHa plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRHa plus flutamide (250 mg, once daily)
Trial: 530571
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment (all four corticosteroids)
Trial: 29531101
Drug: Group-based behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based behavioral activation with mindfulness (BAM), provided with eight 2-hour weekly sessions.
Trial: 25854875
Drug: SSRIs treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRIs treatment (6-week duration)
Trial: 24504810
Drug: Abatacept (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (standard weight-tiered dose, approximating 10 mg/kg)
Trial: 24504810
Drug: Abatacept (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (30 mg/kg for 3 months, then standard weight-tiered dose)
Trial: 10363889
Drug: Polytetrafluoroethylene Patch
RxNorm normalized name: polytetrafluoroethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polytetrafluoroethylene Patch Closure (PTFE)
Trial: 9510277
Drug: Vein Patch
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vein Patch Closure (VPC)
Trial: 508508
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of metronidazole (500 mg)
Trial: 508508
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous dose of metronidazole (500 mg)
Trial: 508508
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of metronidazole (500 mg)
Trial: 30801359
Drug: Bilateral ultrasound-guided
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ultrasound-guided erector spinae plane block using 20 mL of bupivacaine 0.25% on each side
Trial: 30801359
Drug: Bilateral sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral sham erector spinae plane block using 1 mL of normal saline
Trial: 29728074
Drug: Varenicline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline plus 18 mg/mL nicotine e‐cigarette
Trial: 9531251
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg/d + Ticlopidine 2X250 mg/d (Group A)
Trial: 9531251
Drug: Ticlopidine 2X250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 2X250 mg/d (Group B)
Trial: 7980260
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg bd for a minimum of 5 pre-operative days, then intravenously for 2 postoperative days)
Trial: 7980260
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no cimetidine treatment)
Trial: 31754119
Drug: Transmitted drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmitted drug resistance (TDR)
Trial: 31754119
Drug: Pre-treatment HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment HIV resistance testing
Trial: 23733467
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg thrice daily)
Trial: 21791363
Drug: Left Ventricular
RxNorm normalized name: DRESSING,VENTRICULAR ASSIST DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left Ventricular Cardiac Resynchronization Therapy (LV CRT)
Trial: 21791363
Drug: Biventricular Cardiac
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biventricular Cardiac Resynchronization Therapy (Biventricular CRT)
Trial: 8092830
Drug: Imipenem monotherapy
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem monotherapy
Trial: 3382463
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or initial non-drug investigation
Trial: 8201963
Drug: L-phenylalanine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-phenylalanine (10 g)
Trial: 30170260
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) - 385.6 mg EPA and 81.2 mg DHA/capsule, n=33
Trial: 30170260
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (DHA) - 417.8 mg DHA and 50.8 mg EPA/capsule, n=33
Trial: 29132734
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 mg/day) and Vitamin D3 (50,000 IU every two weeks) for 8 weeks
Trial: 24123041
Drug: Docetaxel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (60 mg/m²) plus carboplatin (AUC=6 mg/ml min)
Trial: 24123041
Drug: Paclitaxel (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (200 mg/m²) plus carboplatin (AUC=6 mg/ml min)
Trial: 21235340
Drug: Diamorphine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamorphine treatment (12 months)
Trial: 21235340
Drug: Methadone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone treatment (12 months)
Trial: 16514112
Drug: Three-times-weekly (TIW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-times-weekly (TIW) regimen of clarithromycin, ethambutol, and rifampin
Trial: 426990
Drug: Thiopentone 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 3.5 mg kg‐1
Trial: 7066137
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg kg‐1
Trial: 6196556
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg prizidilol
Trial: 29383550
Drug: Portal message
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Portal message promoting influenza vaccines
Trial: 29383550
Drug: IVR call
RxNorm normalized name: Ivra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVR call promoting influenza vaccines
Trial: 25003289
Drug: Mitomycin-C arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin-C arm of the Radiation Therapy Oncology Group 98-11 trial
Trial: 30698316
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (MED)
Trial: 20556560
Drug: Tapentadol prolonged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol prolonged release (PR; 100‐250 mg twice daily)
Trial: 20556560
Drug: Oxycodone hydrochloride
RxNorm normalized name: Oxycodone Hydrochloride
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone hydrochloride controlled release (CR; 20‐50 mg twice daily)
Trial: 16245247
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus interventional percutaneous transluminal renal artery stenting (PTRS)
Trial: 12400976
Drug: 160 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg/day of megestrol acetate
Trial: 12400976
Drug: 320 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320 mg/day of megestrol acetate
Trial: 12400976
Drug: 160 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg/day and 320 mg/day of megestrol acetate
Trial: 10446821
Drug: IVIG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG group (n = 19), received a commercially available human IgA- and IgM-enriched immunoglobulin preparation (dose, 20 g)
Trial: 2114240
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose (100 g)
Trial: 2114240
Drug: Supramaximal dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supramaximal dose of GHRH (50 micrograms bolus, followed by 100 micrograms/h infusion for 3 h)
Trial: 390336
Drug: Levodopa-carbidopa combination
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa-carbidopa combination (Sinemet)
Trial: 11991768
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g of ginseng root extract (GIN)
Trial: 9855767
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no psychorelaxation therapy)
Trial: 7534777
Drug: Fluocinonide ointment
RxNorm normalized name: Fluocinonide Ointment
DrugBank: Fluocinonide (DB01047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinonide ointment plus prolonged occlusion
Trial: 7057051
Drug: Fluocinonide ointment
RxNorm normalized name: Fluocinonide Ointment
DrugBank: Fluocinonide (DB01047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinonide ointment
Trial: 37870
Drug: Nadolol (beta-blocker),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (beta-blocker), given once daily
Trial: 37870
Drug: Propranolol (beta-blocker),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (beta-blocker), given four times daily
Trial: 31780346
Drug: CBT‐SE (8-session
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT‐SE (8-session cognitive behaviour therapy group intervention)
Trial: 22436337
Drug: Manual interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual interventions (e.g. manipulation, mobilization or soft tissue techniques)
Trial: 18766426
Drug: Anakinra (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (1 mg/kg daily, ≤100 mg/day)
Trial: 17229548
Drug: Prophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis with single pre‐surgical dose of two tablets amoxicillin/clavulanate 1000/62.5 mg
Trial: 17229548
Drug: Pre‐emptive post‐surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐emptive post‐surgery therapy with two tablets amoxicillin/clavulanate 1000/62.5 mg BID for 5 days
Trial: 9757201
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus injection of granisetron
Trial: 9757201
Drug: Intravenous drip
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous drip infusion of granisetron over 30 minutes
Trial: 7525038
Drug: Pamidronate 90
RxNorm normalized name: pamidronate 90 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 90 mg every 4 weeks
Trial: 7525038
Drug: Pamidronate 30
RxNorm normalized name: pamidronate 30 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 30 mg every 2 weeks
Trial: 22961714
Drug: Hepatic arterial
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatic arterial infusion of floxuridine with systemic irinotecan
Trial: 8996762
Drug: Indefinite, high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indefinite, high dose HBIG (10,000 mu or 40,000 mu/dose depending on HBV DNA status pretransplant)
Trial: 8996762
Drug: Indefinite, high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indefinite, high dose HBIG
Trial: 25420455
Drug: MNP +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MNP + Fe (2.5 mg iron as NaFeEDTA)
Trial: 22352120
Drug: Metoprolol XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol XL 50 mg + Amlodipine 5 mg
Trial: 22352120
Drug: Metoprolol XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol XL 25 mg + Amlodipine 2.5 mg
Trial: 22352120
Drug: Metoprolol XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol XL 50 mg
Trial: 22352120
Drug: Metoprolol XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol XL 25 mg
Trial: 9370141
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (45 mg beta-carotene, 825 mg alpha-tocopherol, and 450 mg ascorbic acid daily for three weeks)
Trial: 9370141
Drug: Healthy control
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy control group (N = 10) supplemented with the same doses as BMT(+)
Trial: 23111108
Drug: Internet‐administered cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet‐administered cognitive behavior therapy (iCBT) for 9 weeks
Trial: 20602280
Drug: Chlorhexidine oral
RxNorm normalized name: chlorhexidine Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine oral gel
Trial: 18008240
Drug: Single-dose sulfadoxine-pyrimethamine
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose sulfadoxine-pyrimethamine (SP)
Trial: 15677374
Drug: Daily iron-folic
RxNorm normalized name: folic acid / iron carbonyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron-folic acid (1 tablet/dose, 20 mg elemental iron and 0.1 mg folic acid/tablet)
Trial: 15677374
Drug: Biweekly iron-folic
RxNorm normalized name: folic acid / iron carbonyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biweekly iron-folic acid (2 tablets/dose, 20 mg elemental iron and 0.1 mg folic acid/tablet)
Trial: 11981066
Drug: cerivastatin 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cerivastatin 0.15 mg/day
Trial: 28786530
Drug: Teneligliptin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teneligliptin (20 mg) added to canagliflozin (C + T group)
Trial: 27165661
Drug: Khat (juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Khat (juice mixed with 45 g of ground khat leaves)
Trial: 27165661
Drug: Placebo (33
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (33 ml of fruit juice)
Trial: 17822770
Drug: Voriconazole 200
RxNorm normalized name: voriconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole 200 mg twice daily
Trial: 16286177
Drug: Rhythm-control antiarrhythmic
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhythm-control antiarrhythmic drugs
Trial: 10397563
Drug: ddl plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ddl plus 3TC (300 mg/day)
Trial: 1963170
Drug: MCP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCP with metergoline (10 mg/day p.o. in 5 divided doses for 4 days before MCP)
Trial: 1963170
Drug: MCP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCP with ketanserin (10 mg as a slow 3-min intravenous injection, 5 min before MCP)
Trial: 7074794
Drug: verapamil (480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil (480 mg/day)
Trial: 7074794
Drug: propranolol (160-320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol (160-320 mg/day)
Trial: 30855472
Drug: Variable-rate feedback
RxNorm normalized name: Ferric carbonate, ferric hydroxide, ferrous hydroxide (variable mixture)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variable-rate feedback infusion plus demand dosing
Trial: 30855472
Drug: Constant-rate background
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant-rate background infusion plus demand dosing
Trial: 11939614
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine containing alcohol (0.8 g/kg)
Trial: 9637639
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion (2.5 microg/ml, 10 ng x kg(‐1) x min(‐1))
Trial: 9637639
Drug: Ephedrine infusion
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ephedrine infusion (5 mg/ml, 50 microg x kg(‐1) x min(‐1))
Trial: 28490322
Drug: Video Game
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video Game Therapy (VGT)
Trial: 21146460
Drug: CVD 909
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 909 vaccine
Trial: 16776759
Drug: Direct laser
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct laser treatment
Trial: 9262037
Drug: Tetrachlorodecaoxide (TCDO),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrachlorodecaoxide (TCDO), 10 ml, twice daily, swish and swallow, for 7 days
Trial: 30853771
Drug: Active CAMBRA
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active CAMBRA treatment
Trial: 1947515
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as actually received
Trial: 11915060
Drug: Continuous intrabursal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intrabursal infusion of 0.5% bupivacaine and 2 mg morphine (5 mL bolus and 40 mL maintenance at 0.5 mL/h)
Trial: 7796496
Drug: Bolus plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus plus infusion c7E3 Fab
Trial: 2194849
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of monoethyl fumarate
Trial: 694829
Drug: Heparin analogue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin analogue
Trial: 30905157
Drug: FXR agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FXR agonist GW4064
Trial: 11225746
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (Humalog)
Trial: 3391871
Drug: Erythromycin acistrate
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin acistrate (EA) 400 mg tid
Trial: 21443599
Drug: Alitretinoin 20
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 20 mg, once daily for 14 days
Trial: 21443599
Drug: Alitretinoin 40
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 40 mg, once daily for 14 days
Trial: 19304097
Drug: Low vacuum
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low vacuum group (vacuum 200 mm Hg, flow rate 20 cc/min)
Trial: 19304097
Drug: High vacuum
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High vacuum group (vacuum 400 mm Hg, flow rate 40 cc/min)
Trial: 16387508
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (CC and BC)
Trial: 16387508
Drug: Overall comparison
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall comparison of CC and BC
Trial: 8602598
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 g pectin/d)
Trial: 29668213
Drug: Prescription of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription of ACE inhibitor or ARB for high-risk patients
Trial: 16094663
Drug: Venlafaxine (75-225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (75-225 mg/day)
Trial: 24188161
Drug: Milnacipran (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran (100 mg/day)
Trial: 11535321
Drug: Twinrix (720
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twinrix (720 EL.U inactivated hepatitis A antigen and 20 mcg recombinant hepatitis B surface antigen per milliliter) on a 0, 1, 6 month schedule
Trial: 20002596
Drug: Milnacipran 200
RxNorm normalized name: MILNACIPRAN
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Milnacipran 200 mg/day